Compare Angi Inc (ANGI) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Angi Inc vs Merck & Co., Inc. — how do they compare? Angi Inc trades at $6.28 (market cap $252.19M), while Merck & Co., Inc. trades at $124.03 (market cap $305.12B). The key difference: Merck & Co., Inc. is far larger — about 1209.9× Angi Inc's market cap, and Merck & Co., Inc. pays a 2.75% dividend while Angi Inc pays none. Which is the better fit depends on your goals.
| ANGI | MRK | |
|---|---|---|
Market Cap | $252.19M | $305.12B |
Sector | Media | Health |
52-Week High | $18.90 | $129.52 |
52-Week Low | $4.78 | $77.60 |
Enterprise Value | $479.00M | $348.54B |
Dividend Yield | — | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MRK trades at $124.03, up 0.4% on the day, with a bullish technical signal from moving averages but mixed oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 loss narrower than expected. Revenue grew to $65.01B in 2025, and net income margin improved to 28.07%. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, reflecting strategic growth initiatives.
The outlook remains positive with a consensus price target of $135.14, implying ~9% upside. Risks include rising debt levels and competitive pressures in pharma. Institutional ownership trends show increased buying, supporting bullish sentiment. Earnings growth and pipeline expansion are key catalysts, though macroeconomic and regulatory headwinds warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Angi Inc
Angi Inc connects quality home service professionals across different categories, from repairing and remodeling to cleaning and landscaping, with consumers. It has two geographical segments namely North America (the United States and Canada), which primarily includes the operations HomeAdvisor, Angie's List, Handy, mHelpDesk, HomeStars, and Fixd Repair
Read more on ANGI →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
